Prévisions du marché européen de la découverte d\'anticorps jusqu\'en 2030 - Analyse régionale - par type d\'anticorps (anticorps monoclonaux, anticorps polyclonaux et autres), nature (humain et humanisé, chimérique et murin), services (phage display, hybridome, animal transgénique, cellule unique et affichage de levure) et utilisateur final (sociétés pharmaceutiques et biotechnologiques, laboratoires de recherche et autres)
L\'augmentation de l\'incidence du cancer stimule le marché européen de la découverte d\'anticorps
Selon les estimations de l\'Observatoire mondial du cancer (GLOBOCAN) publiées en 2020, il y avait 19,3 millions de cas de cancer dans le monde. D\'ici janvier 2030, la population de survivants du cancer devrait atteindre 22,1 millions, ce qui peut être principalement associé au vieillissement de la population. Le poumon, le sein, le colorectal, la prostate et le sein sont parmi les types de cancer les plus fréquemment signalés. L\'augmentation de l\'incidence du cancer a suscité des inquiétudes dans le monde entier. Vous trouverez ci-dessous la liste des cas de cancer courants signalés dans le monde en 2020.
Nouveaux cas de cancer dans le monde, en 2020
Sr. Non.
Type de cancer
Nombre de cas (millions)
1
Estomac
1,09
2
Peau (non mélanome)
1,2
3
Prostate
1,41
4
Côlon et rectum
1,93
5
Poumon
2,21
6
Sein
2,26
Source : Organisation mondiale de la Santé, février 2020
Le cancer est désormais une maladie liée au mode de vie fréquemment observée chez les personnes ayant de mauvaises habitudes alimentaires et celles qui ne pratiquent pas beaucoup d\'activités physiques. La consommation fréquente d\'alcool et de tabac augmente le risque de développer un cancer. Les maladies infectieuses chroniques dans les pays à revenu faible et intermédiaire peuvent aggraver davantage les facteurs de risque de cancer. Une recrudescence de l\'incidence du cancer indique la nécessité de traitements innovants contre le cancer. Les anticorps monoclonaux représentent une classe prometteuse d\'agents anticancéreux ciblés qui améliorent la capacité naturelle du système immunitaire à supprimer l\'activité des cellules cancéreuses et à éliminer les cellules cancéreuses. Les conjugués anticorps-médicament (ADC) ont également montré des résultats prometteurs dans le traitement du cancer. En outre, les progrès de la biotechnologie moderne permettent aux chercheurs et aux entreprises de fournir de nouveaux anticorps bien conçus, ouvrant la voie à des traitements efficaces de divers types de cancer. Ainsi, l\'incidence croissante de différents types de cancer stimule la croissance du marché de la découverte d\'anticorps.
Aperçu du marché européen de la découverte d\'anticorps
Le marché européen de la découverte d\'anticorps est segmenté en Allemagne, au Royaume-Uni, en France, en Italie, en Espagne et dans le reste de l\'Europe. La région détient une part importante du marché mondial. Il devrait enregistrer un taux de croissance robuste dans les années à venir en raison de l\'utilisation croissante d\'anticorps monoclonaux dans les applications de R&D, les thérapies contre le cancer et la gestion des troubles immunologiques. Français En outre, le besoin croissant de systèmes de gestion des données des patients, la prévalence des maladies chroniques et les initiatives gouvernementales pour la mise en œuvre de services d\'anticorps devraient offrir des opportunités de croissance pour le marché de la découverte d\'anticorps dans des pays comme la France, l\'Italie et l\'Espagne.
Chiffre d\'affaires et prévisions du marché européen de la découverte d\'anticorps jusqu\'en 2030 (milliards de dollars américains)
Segmentation du marché européen de la découverte d\'anticorps
Le marché européen de la découverte d\'anticorps est classé en type d\'anticorps, nature, services, utilisateur final et pays.
Sur la base du type d\'anticorps, le marché européen de la découverte d\'anticorps est segmenté en anticorps monoclonaux, anticorps polyclonaux et autres. Le segment des anticorps monoclonaux détenait la plus grande part de marché européenne de la découverte d\'anticorps en 2022.
En termes de nature, le marché européen de la découverte d\'anticorps est segmenté en humain et humanisé, chimérique et murin. Le segment humain et humanisé détenait la plus grande part de marché européenne de la découverte d\'anticorps en 2022.
Par services, le marché européen de la découverte d\'anticorps est divisé en phage display, hybridome, animal transgénique, cellule unique et affichage de levure. Le segment phage display détenait la plus grande part de marché européenne de la découverte d\'anticorps en 2022.
Sur la base de l\'utilisateur final, le marché européen de la découverte d\'anticorps est classé en sociétés pharmaceutiques et biotechnologiques, laboratoires de recherche et autres. Le segment des sociétés pharmaceutiques et biotechnologiques détenait la plus grande part de marché européenne de la découverte d\'anticorps en 2022.
Sur la base du pays, le marché européen de la découverte d\'anticorps est classé en Allemagne, Royaume-Uni, France, Italie, Espagne et reste de l\'Europe. L\'Allemagne a dominé la part de marché européenne de la découverte d\'anticorps en 2022.
Charles River Laboratories International Inc, Creative Biolabs Inc, Evotec SE, Sartorius AG, Aragen Life Sciences Ltd, Twist Bioscience Corp et Biocytogen Pharmaceuticals Beijing Co Ltd. sont quelques-unes des principales sociétés opérant sur le marché européen de la découverte d\'anticorps.
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Antibody Discovery Market - Key Market Dynamics
4.1 Market Drivers
4.1.1 Increasing Investments in Research & Development
4.1.2 Rising Incidence of Cancer
4.2 Market Restraints
4.2.1 High Cost of Production
4.3 Market Opportunities
4.3.1 Proliferation of Biotechnology Industry in Developing Regions
4.4 Future Trends
4.4.1 Developments for Custom Antibodies
4.5 Impact of Drivers and Restraints:
5. Antibody Discovery Market - Europe Market Analysis
5.1 Europe Antibody Discovery Market Revenue (US$ Million), 2020-2030
6. Europe Antibody Discovery Market Analysis - by Antibody Type
6.1 Overview
6.2 Monoclonal Antibodies
6.2.1 Overview
6.2.2 Monoclonal Antibodies: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
6.3 Polyclonal Antibodies
6.3.1 Overview
6.3.2 Polyclonal Antibodies: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Others
6.4.1 Overview
6.4.2 Others: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
7. Europe Antibody Discovery Market Analysis - by Nature
7.1 Overview
7.2 Human and Humanized
7.2.1 Overview
7.2.2 Human and Humanized: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
7.3 Chimeric
7.3.1 Overview
7.3.2 Chimeric: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Murine
7.4.1 Overview
7.4.2 Murine: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
8. Europe Antibody Discovery Market Analysis - by Services
8.1 Overview
8.2 Phage Display
8.2.1 Overview
8.2.2 Phage Display: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
8.3 Hybridoma
8.3.1 Overview
8.3.2 Hybridoma: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Transgenic Animal
8.4.1 Overview
8.4.2 Transgenic Animal: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Yeast Display
8.5.1 Overview
8.5.2 Yeast Display: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
8.6 Single Cell
8.6.1 Overview
8.6.2 Single Cell: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
9. Europe Antibody Discovery Market Analysis - by End User
9.1 Overview
9.2 Pharmaceutical and Biotechnology Companies
9.2.1 Overview
9.2.2 Pharmaceutical and Biotechnology Companies: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
9.3 Research Laboratories
9.3.1 Overview
9.3.2 Research Laboratories: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Others
9.4.1 Overview
9.4.2 Others: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
10. Europe Antibody Discovery Market - Country Analysis
10.1 Europe Antibody Discovery Market, Revenue and Forecast to 2030
10.1.1 Europe: Antibody Discovery Market - Revenue and Forecast Analysis - by Country
10.1.1.1 UK
10.1.1.1.1 Overview
10.1.1.1.2 UK: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.1.3 UK: Antibody Discovery Market Breakdown, by Antibody Type
10.1.1.1.4 UK: Antibody Discovery Market Breakdown, by Nature
10.1.1.1.5 UK: Antibody Discovery Market Breakdown, by Services
10.1.1.1.6 UK: Antibody Discovery Market Breakdown, by End User
10.1.1.2 Germany
10.1.1.2.1 Overview
10.1.1.2.2 Germany: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.3 Germany: Antibody Discovery Market Breakdown, by Antibody Type
10.1.1.2.4 Germany: Antibody Discovery Market Breakdown, by Nature
10.1.1.2.5 Germany: Antibody Discovery Market Breakdown, by Services
10.1.1.2.6 Germany: Antibody Discovery Market Breakdown, by End User
10.1.1.3 France
10.1.1.3.1 Overview
10.1.1.3.2 France: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.3 France: Antibody Discovery Market Breakdown, by Antibody Type
10.1.1.3.4 France: Antibody Discovery Market Breakdown, by Nature
10.1.1.3.5 France: Antibody Discovery Market Breakdown, by Services
10.1.1.3.6 France: Antibody Discovery Market Breakdown, by End User
10.1.1.4 Italy
10.1.1.4.1 Overview
10.1.1.4.2 Italy: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.4.3 Italy: Antibody Discovery Market Breakdown, by Antibody Type
10.1.1.4.4 Italy: Antibody Discovery Market Breakdown, by Nature
10.1.1.4.5 Italy: Antibody Discovery Market Breakdown, by Services
10.1.1.4.6 Italy: Antibody Discovery Market Breakdown, by End User
10.1.1.5 Spain
10.1.1.5.1 Overview
10.1.1.5.2 Spain: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.5.3 Spain: Antibody Discovery Market Breakdown, by Antibody Type
10.1.1.5.4 Spain: Antibody Discovery Market Breakdown, by Nature
10.1.1.5.5 Spain: Antibody Discovery Market Breakdown, by Services
10.1.1.5.6 Spain: Antibody Discovery Market Breakdown, by End User
10.1.1.6 Rest of Europe
10.1.1.6.1 Overview
10.1.1.6.2 Rest of Europe: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.6.3 Rest of Europe: Antibody Discovery Market Breakdown, by Antibody Type
10.1.1.6.4 Rest of Europe: Antibody Discovery Market Breakdown, by Nature
10.1.1.6.5 Rest of Europe: Antibody Discovery Market Breakdown, by Services
10.1.1.6.6 Rest of Europe: Antibody Discovery Market Breakdown, by End User
11. Antibody Discovery Market-Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Antibody Discovery Market
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Charles River Laboratories International Inc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Creative Biolabs Inc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Evotec SE
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Sartorius AG
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Aragen Life Sciences Ltd
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Twist Bioscience Corp
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Biocytogen Pharmaceuticals Beijing Co Ltd
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
List of Tables
Table 1. Europe Antibody Discovery Market Segmentation
Table 2. New Cancer Cases Worldwide, in 2020
Table 3. UK: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
Table 4. UK: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
Table 5. UK: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
Table 6. UK: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 7. Germany: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
Table 8. Germany: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
Table 9. Germany: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
Table 10. Germany: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 11. France: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
Table 12. France: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
Table 13. France: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
Table 14. France: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 15. Italy: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
Table 16. Italy: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
Table 17. Italy: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
Table 18. Italy: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 19. Spain: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
Table 20. Spain: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
Table 21. Spain: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
Table 22. Spain: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 23. Rest of Europe: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
Table 24. Rest of Europe: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
Table 25. Rest of Europe: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
Table 26. Rest of Europe: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 27. Recent Inorganic Growth Strategies in the Antibody Discovery Market
Table 28. Recent Organic Growth Strategies in the Antibody Discovery Market
Table 29. Glossary of Terms, Antibody Discovery Market
List of Figures
Figure 1. Europe Antibody Discovery Market Segmentation, by Country
Figure 2. Europe Antibody Discovery Market - Key Market Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Europe Antibody Discovery Market Revenue (US$ Million), 2020 - 2030
Figure 5. Europe Antibody Discovery Market Share (%) - by Antibody Type (2022 and 2030)
Figure 6. Monoclonal Antibodies: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Polyclonal Antibodies: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Others: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Europe Antibody Discovery Market Share (%) - by Nature (2022 and 2030)
Figure 10. Human and Humanized: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Chimeric: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Murine: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Europe Antibody Discovery Market Share (%) - by Services (2022 and 2030)
Figure 14. Phage Display: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Hybridoma: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Transgenic Animal: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Yeast Display: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Single Cell: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Europe Antibody Discovery Market Share (%) - by End User (2022 and 2030)
Figure 20. Pharmaceutical and Biotechnology Companies: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Research Laboratories: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Others: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Europe: Antibody Discovery Market, by Key Country - Revenue (2022) (US$ Million)
Figure 24. Europe: Antibody Discovery Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 25. UK: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
Figure 26. Germany: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
Figure 27. France: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
Figure 28. Italy: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
Figure 29. Spain: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
Figure 30. Rest of Europe: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
Figure 31. Growth Strategies in the Antibody Discovery Market
- Charles River Laboratories International Inc
- Creative Biolabs Inc
- Evotec SE
- Sartorius AG
- Aragen Life Sciences Ltd
- Twist Bioscience Corp
- Biocytogen Pharmaceuticals Beijing Co Ltd
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe antibody discovery market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Europe antibody discovery market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the Europe antibody discovery market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.